About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Hematology
›
top-articles
Department of Hematology
133
(top 1%)
papers
6.4K
(top 1%)
citations
39
(top 1%)
h
-index
80
(top 1%)
g
-index
143
all documents
6.7K
doc citations
1.3K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
Leukemia
2013
540
2
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment
Leukemia
2008
443
3
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia
Blood
2007
419
4
Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications
Annals of Internal Medicine
2001
351
5
Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden
Leukemia
2007
328
6
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
Haematologica
2013
268
7
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
Leukemia
2005
236
8
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis
Blood
2007
233
9
GATA-1 as a Regulator of Mast Cell Differentiation Revealed by the Phenotype of the GATA-1low Mouse Mutant
Journal of Experimental Medicine
2003
203
10
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
Leukemia
2014
198
11
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
Blood
2008
192
12
Second Allogeneic Bone Marrow Transplantation in Acute Leukemia: Results of a Survey by the European Cooperative Group for Blood and Marrow Transplantation
Journal of Clinical Oncology
2001
173
13
Advances in Understanding and Management of Myeloproliferative Neoplasms
Ca-A Cancer Journal for Clinicians
2009
170
14
Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia
Haematologica
2008
146
15
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation
Blood
2009
131
16
Molecular Profiling of CD34+Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (WT1)
Stem Cells
2007
111
17
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey
Blood
2008
106
18
Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia
Blood
2008
100
19
Azacitidine for the treatment of lower risk myelodysplastic syndromes
Cancer
2010
98
20
Bone Marrow Mesenchymal Stromal Cells Stimulate Skeletal Myoblast Proliferation through the Paracrine Release of VEGF
PLoS ONE
2012
93
21
Hypermethylation of
CXCR4
Promoter in CD34+ Cells from Patients with Primary Myelofibrosis
Stem Cells
2008
91
22
Expression of nucleoside-metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine
Leukemia
2014
80
23
Thrombocytosis and Thrombosis
Hematology American Society of Hematology Education Program
2007
73
24
MicroRNA expression profile in granulocytes from primary myelofibrosis patients
Experimental Hematology
2007
71
25
A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis
Leukemia
2006
68
26
The ‘GGCC’ haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera
Leukemia
2009
68
27
Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant
Bone Marrow Transplantation
1998
66
28
Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group
Transplantation
2009
64
29
Abnormalities of GATA-1 in Megakaryocytes from Patients with Idiopathic Myelofibrosis
American Journal of Pathology
2005
62
30
A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia
Leukemia
2018
58
31
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi
Haematologica
2014
55
32
Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria
Blood
2007
54
33
The size of duplication does not add to the prognostic significance of FLT3 internal tandem duplication in acute myeloid leukemia patients
Leukemia
2006
51
34
Insights into JAK2-V617F mutation in CML
Lancet Oncology, The
2007
50
35
Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group
Bone Marrow Transplantation
2007
50
36
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia
American Journal of Hematology
2010
48
37
HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry
Bone Marrow Transplantation
2009
48
38
Safety of Bone Marrow Stem Cell Donation: A Review
Transplantation Proceedings
2010
46
39
Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study
Lancet Haematology,the
2018
44
40
A Phase I Study of the Proteasome Inhibitor Bortezomib in Patients with Myelofibrosis.
Blood
2007
39
41
Characterization and discovery of novel miRNAs and moRNAs in JAK2V617F-mutated SET2 cells
Blood
2012
34
42
Epstein–Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation
Leukemia and Lymphoma
2006
33
43
Percutaneous vertebroplasty and kyphoplasty in patients with multiple myeloma
European Journal of Haematology
2006
32
44
A Phase 2 Study of INCB018424, An Oral, Selective JAK1/JAK2 Inhibitor, in Patients with Advanced Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Refractory to Hydroxyurea.
Blood
2009
29
45
Comparative Proteomic Analysis of Chronic Myelogenous Leukemia Cells: Inside the Mechanism of Imatinib Resistance
Journal of Proteome Research
2007
28
46
Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues
Leukemia
2009
27
47
Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life study
Bone Marrow Transplantation
2021
27
48
Searching for the Magic Bullet Against Cancer: The Butyrate Saga
Leukemia and Lymphoma
2001
26
49
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B‐cell lymphomas and comparison with the commonly used therapies
European Journal of Haematology
2009
26
50
Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera
Blood
2011
26
site/software ©
exaly
; All materials licenced under
CC by-SA
.